301080 Stock Overview
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Acrobiosystems Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥37.54 |
| 52 Week High | CN¥74.00 |
| 52 Week Low | CN¥33.00 |
| Beta | 0.69 |
| 1 Month Change | -6.03% |
| 3 Month Change | -17.53% |
| 1 Year Change | -45.28% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301080 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 4.3% | -0.2% | -0.3% |
| 1Y | -45.3% | -25.2% | -14.6% |
Return vs Industry: 301080 underperformed the CN Biotechs industry which returned -24.2% over the past year.
Return vs Market: 301080 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 301080 volatility | |
|---|---|
| 301080 Average Weekly Movement | 8.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 301080's share price has been volatile over the past 3 months.
Volatility Over Time: 301080's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 688 | Yiding Chen | www.acrobiosystems.cn |
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization.
Acrobiosystems Co.,Ltd. Fundamentals Summary
| 301080 fundamental statistics | |
|---|---|
| Market cap | CN¥4.44b |
| Earnings (TTM) | CN¥166.14m |
| Revenue (TTM) | CN¥534.43m |
27.1x
P/E Ratio8.4x
P/S RatioIs 301080 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301080 income statement (TTM) | |
|---|---|
| Revenue | CN¥534.43m |
| Cost of Revenue | CN¥68.44m |
| Gross Profit | CN¥465.99m |
| Other Expenses | CN¥299.85m |
| Earnings | CN¥166.14m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 87.19% |
| Net Profit Margin | 31.09% |
| Debt/Equity Ratio | 0% |
How did 301080 perform over the long term?
See historical performance and comparison